Review: Adjuvant recombinant subunit vaccine prevents herpes zoster more than live attenuated vaccine in adults ≥ 50 years
- PMID: 30776803
- DOI: 10.7326/ACPJ201902190-014
Review: Adjuvant recombinant subunit vaccine prevents herpes zoster more than live attenuated vaccine in adults ≥ 50 years
Comment on
-
Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis.BMJ. 2018 Oct 25;363:k4029. doi: 10.1136/bmj.k4029. BMJ. 2018. PMID: 30361202 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical